A Retrospective Study on the Clinical Safety of Bee Venom Pharmacopuncture at Craniofacial Acupuncture Points for the Treatment of Facial Disorders원문보기
Lee, Chang Hee
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital)
,
Yoon, Jin-Young
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital)
,
Shim, Sung-Eun
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital)
,
Kim, Jeong Hyun
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital)
,
Kim, Jun-Yeon
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital)
,
Kim, Ha-Na
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital)
,
Hwang, Ji-Min
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital)
,
Kim, Jung-Hyun
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital)
,
Goo, Bon Hyuk
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital)
,
Park, Yeon-Cheol
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital)
,
Seo, Byung-Kwan
(Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine)
,
Baek, Yong-Hyeon
,
Nam, Sang-Soo
Background: This study was designed to evaluate the clinical safety of Bee Venom (BV) pharmacopuncture at craniofacial acupuncture points. Methods: This was a retrospective study of 108 patients diagnosed with peripheral facial paralysis, trigeminal neuralgia, or facial spasm who were admitted to Ky...
Background: This study was designed to evaluate the clinical safety of Bee Venom (BV) pharmacopuncture at craniofacial acupuncture points. Methods: This was a retrospective study of 108 patients diagnosed with peripheral facial paralysis, trigeminal neuralgia, or facial spasm who were admitted to Kyung Hee University Korean Medicine Hospital at Gangdong, from April 1st, 2017 to August 30th, 2017. Patients were allocated into either, Group 1 (the non-allergy group of patients who did not have an allergic reaction to BV) or Group 2, the group who had allergic reactions to BV. To evaluate the clinical safety of BV pharmacopuncture after each treatment, several criteria were used to measure any side effects: outcome, Common Terminology Criteria for Adverse Events scale, Mueller HL scale, treatment decision after adverse reaction, causality, measures performed for patients with adverse reactions, and efficacy assessment. Results: BV pharmacopuncture delivered in 0.1-0.2 mL at a concentration of 1:30,000 at the craniofacial acupuncture points, showed no statistically significant differences in baseline characteristics between non-allergy Group 1 and allergy Group 2. Amongst the 108 patients, 11 reported side effects after BV pharmacopuncture treatment. These adverse events included rash (n = 7), pruritus (n = 5), swelling (n = 1), vesicles (n = 1), erythema (n = 1), and hives (n = 1). All side effects resolved without sequelae. Conclusion: In this study, BV pharmacopuncture delivered at low doses at the craniofacial acupuncture points, resulted in 10% of patients experiencing non serious side effects suggesting that BV pharmacopuncture was clinically well tolerated.
Background: This study was designed to evaluate the clinical safety of Bee Venom (BV) pharmacopuncture at craniofacial acupuncture points. Methods: This was a retrospective study of 108 patients diagnosed with peripheral facial paralysis, trigeminal neuralgia, or facial spasm who were admitted to Kyung Hee University Korean Medicine Hospital at Gangdong, from April 1st, 2017 to August 30th, 2017. Patients were allocated into either, Group 1 (the non-allergy group of patients who did not have an allergic reaction to BV) or Group 2, the group who had allergic reactions to BV. To evaluate the clinical safety of BV pharmacopuncture after each treatment, several criteria were used to measure any side effects: outcome, Common Terminology Criteria for Adverse Events scale, Mueller HL scale, treatment decision after adverse reaction, causality, measures performed for patients with adverse reactions, and efficacy assessment. Results: BV pharmacopuncture delivered in 0.1-0.2 mL at a concentration of 1:30,000 at the craniofacial acupuncture points, showed no statistically significant differences in baseline characteristics between non-allergy Group 1 and allergy Group 2. Amongst the 108 patients, 11 reported side effects after BV pharmacopuncture treatment. These adverse events included rash (n = 7), pruritus (n = 5), swelling (n = 1), vesicles (n = 1), erythema (n = 1), and hives (n = 1). All side effects resolved without sequelae. Conclusion: In this study, BV pharmacopuncture delivered at low doses at the craniofacial acupuncture points, resulted in 10% of patients experiencing non serious side effects suggesting that BV pharmacopuncture was clinically well tolerated.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
대상 데이터
From April 1st, 2017 to August 30th, 2017, 108 patients were admitted to Kyung Hee University Korean Medicine Hospital at Gangdong with facial disorders such as peripheral facial paralysis, trigeminal neuralgia, or facial spasm and evaluated for suitability for treatment with BV pharmacopuncture Kyung Hee University Korean Medicine Hospital Gangdong. Prior to BV pharmacopuncture treatment, a BV skin test was performed to determine any possible allergic response.
이론/모형
The Chi-Square test or Fisher’s exact test was used for categorical variables to compare differences in general characteristics between the groups.
0 (IBM Co, Armonk, NY, USA), and the values were expressed as mean ± SD. The Independent t test or the Mann-Whitney U test was used for continuous variables. The Chi-Square test or Fisher’s exact test was used for categorical variables to compare differences in general characteristics between the groups.
참고문헌 (24)
Kwon KR, Koh HK, Kim CH. The study of the introduction of Bee venom Acupuncture. J Korean Acupunct Moxib Soc 1994;11:160. [in Korean].
Korean Acupuncture & Moxibustion society text-book compilation committee. Acupuncture and Moxibusion, 2nd ed. Korea: Jipmoondang; 2008. 408 p. [in Korean].
Chen J, Lariviere WR. The nociceptive and anti-nociceptive effects of bee venom injection and therapy: A double-edged sword. Prog Neurobiol 2010;92:151-183.
Yang KR, Song HS. Effect of bee venom pharmacopuncture complex therapy on peripheral facial paralysis. J Pharmacopuncture 2009;26:29-37. [in Korean].
Yang TJ, Lee JH, Kim SW, Jeong JY, Wei TS. A case of trigeminal neuralgia Treated by Korean Medical Treatment Including Bee venom Pharmacopuncture. Korean J Acupunct 2014;4:225-228. [in Korean].
Jang GC, Chang YS, Choi SH, Song WJ, Lee SY, Park HS et al. Overview of anaphylaxis in Korea: diagnosis and management. Allergy Asthma Respir Dis 2013;1:181-196. [in Korean].
Jung DJ, Lee HG, Choi YM, Song BY, Yook TH, Kim JU. The clinical study on 130 cases with Sweet bee venom Treatment. J Korean Acupunct Moxib Soc 2013;30:211-217. [in Korean].
Kang JW, Park DS, Lee SH, Lee JD. A study on bee sting therapy: based on ‘research on bee sting therapy’ of monthly yangbonggye. J Korean Acupunct Moxib Soc 2009;26:135-151. [in Korean].
Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007;7:337-341.
Hansen LG, Halken S, Moller A, Osterballe O. Prediction of allergy from family history and cord blood IgE levels. A follow-up at the age of 5 years. Cord blood IgE IV. Pediatr Allergy Immunol 1993;4:34-40.
US Department of Health and Human Services [Internet]. Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0. USA: National Institutes of Health; 2009. Available from: https://www.eortc.be/services/doc/ctc/ctcae_4.03_2010-06-14_quickreference_5x7.pdf.
Edwards IR, Biriell C. Harmonisation in Pharmacovigilance. Drug Saf 1994;10:93-102.
Choi JY, Lee H, Kang JH, Kim YI, Kim JH, Lee SH et al. Comparative study of general oriental medical treatment and bee venom pharmacopuncture on acute peripheral facial paralysis patient with postauricular pain. J Kor Acupunct Moxib Soc 2009;26:95-103. [in Korean].
Clark S, Camargo CA. Epidemiology of anaphylaxis. Immunol Allergy Clin North Am 2007;27:145-163.
Lee SK, Ye YM, Park HS, Jang GC, Lee YK, Park HK et al. Hymenoptera venom anaphylaxis in adult Korean; a multicenter retrospective case study. Allergy Asthma Respir Dis 2014;2:344-351. [in Korean].
Sturm GJ, Heinemann A, Schuster C, Wiednig M, Groselj-Strele A, Sturm EM et al. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy. Allergy 2007;62:884-889.
Guan K, Li LS, Yin J. Use of sIgE/T-IgE in predicting Systemic Reactions: retrospective analysis of 54 honeybee venom allergy cases in north china. Chin Med J 2016;129:2091-2095.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.